Pharma Drug Discovery

News
The Phase 1 trial of BMS-986506 highlights the potential of molecular glue degraders in targeting kidney cancer and other diseases.
Webinars
Available on Demand
Discover innovative solutions to streamline lab processes, increase efficiency, and reduce human error.Blogs
A comparative study between the Supel™ BioSPME 96-Pin device and the rapid equilibrium dialysis technique.











